PYRIDINYL SUBSTITUTED OXOISOINDOLINE COMPOUNDS

Disclosed are compounds of Formula (I):or a salt thereof, wherein R1, R2, R4, R6, m, and n are defined herein. Also disclosed are methods of using such compounds to inhibit Helios protein, and pharmaceutical compositions comprising such compounds. These compounds are useful in the treatment of viral infections and proliferative disorders, such as cancer..

Medienart:

Patent

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Europäisches Patentamt - (2024) vom: 14. Feb. Zur Gesamtaufnahme - year:2024

Sprache:

Englisch

Beteiligte Personen:

CHEN YAN [VerfasserIn]
KUMI GODWIN KWAME [VerfasserIn]
HUANG AUDRIS [VerfasserIn]
NAIR SATHEESH KESAVAN [VerfasserIn]
SHIMPUKADE BHARAT DINKAR [VerfasserIn]
PENMETSA SURESH BABU VISHWA KRISHNA [VerfasserIn]
BALOG JAMES AARON [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
C07D: Heterocyclic compounds (macromolecular compounds c0 (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2024-02-14, Last update posted on www.tib.eu: 2024-04-23, Last updated: 2024-04-26

Patentnummer:

EP4320112

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA000209554